EssilorLuxottica (ESLOY) has a profit margin of 8.64%, below the Healthcare sector average of 19.13%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for ESLOY is 8.64% as of June 2026. That compares with 9.16% in the prior-year period — down 5.7% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside EssilorLuxottica's historical trend and sector peers before judging valuation or financial health.
Over the past year, ESLOY's profit margin moved from 9.16% to 8.64% — a 5.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in EssilorLuxottica's valuation or profitability profile.
Against Healthcare companies, ESLOY currently prints 8.64% for profit margin, while the sector average sits near 19.13%. That is roughly 54.8% below the sector mean. Large gaps often invite a closer look at EssilorLuxottica's growth, margins, and balance sheet.
Profit Margin shows how effectively EssilorLuxottica converts resources into returns. At 8.64%, ESLOY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 9.16% in the prior-year period — down 5.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ESLOY's profit margin (8.64%), review year-over-year change from 9.16%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.